NCT01166568View on ClinicalTrials.gov

Trial of the PresVIEW Implant for the Improvement of Near Vision in Patients With Presbyopia

NACompletedINTERVENTIONAL
Enrollment

337

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Presbyopia
Interventions
DEVICE

PresVIEW Scleral Implants

Subjects are implanted with the PresView Scleral Spacing Implants and followed for 24 months.

Trial Locations (14)

14228

Fichte, Endl and Elmer Eyecare Creekside Center, Amherst

27410

Southeastern Eye Center, Greensboro

37203

Wang Vision Institute, Nashville

40206

The Eye Care Institute, Louisville

48034

Associated Vision Consultants, Southfield

60016

The Midwest Center for Sight, Des Plaines

60046

Jacksoneye, Lake Villa

60148

Vision/Advanced Eye Center, Lombard

68144

Cornea Associates, Omaha

74133

Eye Associates of South Tulsa, Tulsa

78212

Braverman-Terry-Oei-Eye Associates, San Antonio

78215

The Center for Corrective Eye Surgery, San Antonio

90210

Boxer-Wachler Vision Institute, Beverly Hills

92122

Gordon-Weiss-Schanzlin Vision Institute, San Diego

All Listed Sponsors
lead

Refocus Group, Inc.

INDUSTRY

NCT01166568 - Trial of the PresVIEW Implant for the Improvement of Near Vision in Patients With Presbyopia | Biotech Hunter | Biotech Hunter